1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "碘131" 4 results
        • Diagnostic Value of Serum Thyroglobulin, Diagnostic 131I Whole-body Scan and Neck Ultrasonography for Evaluation of Lymph Node Metastasis and Recurrence of Differentiated Thyroid Cancer

          ObjectiveTo compare the diagnostic efficacy of serum thyroglobulin (Tg), diagnostic 131I whole-body scan (D-WBS), neck ultrasound for diagnosing metastasis and recurrence of differentiated thyroid carcinoma (DTC). MethodsFrom May to June 2011, fifty follow-up DTC patients were collected retrospectively 6 months or more after 131I ablation therapy following total-thyroidectomy or near-total thyroidectomy. The diagnostic standard for DTC metastasis and relapse were based on serum Tg, D-WBS, neck ultrasound and chest CT. Diagnostic 2 by 2 table was employed for calculating the sensitivity, specificity, accuracy of the methods. ResultsThe sensitivity, specificity, accuracy, positive predictive value, negative predictive value of TgIMA and D-WBS parallel experiments were 100.0%, 92.9%, 96.0%, 91.7%, and 100.0% respectively. ConclusionTgIMA combined with D-WBS parallel test in diagnosis of DTC metastasis and recurrence has the highest accuracy.

          Release date: Export PDF Favorites Scan
        • 碘131治療兒童甲狀腺乳頭狀癌伴頸部淋巴結轉移的護理一例

          Release date: Export PDF Favorites Scan
        • 分化型甲狀腺癌患者術后碘131治療的不良反應護理

          目的 總結核醫學科分化型甲狀腺癌術后患者口服碘131(131I)治療的常見不良反應及處理。 方法 收集2013年7月-2014年6月經131I治療的分化型甲狀腺癌術后患者970例,總結131I治療過程中出現的不良反應,以及針對各種不良反應給予的相應處理措施。 結果 970例分化型甲狀腺癌術后患者均順利出院,502例出現不良反應,不良反應發生率為5 1.75%。其中頭頸部反應258例,消化道反應398例,造血系統反應2例,生殖系統反應1例。在發生不良反應的502例患者中,401例患者出現的不良反應在其出院時均得到有效緩解,53例患者在出院1個月后電話隨訪中告知不良反應已消失,48例訴癥狀已逐漸減輕。 結論 131I治療分化型甲狀腺癌可出現一過性的不良反應。對癥處理后均可恢復正常。

          Release date: Export PDF Favorites Scan
        • 甲狀腺功能亢進碘131治療后遲發性放射性甲狀腺炎的治療護理一例

          Release date: Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品